Montreal, November 22, 2012 More than a century ago, a brilliant young chemist and physicist named Marie Curie, won a Nobel Prize for her ground-breaking discoveries in radioactivity.
Emma Martn Rodrguez, a post-doctoral researcher in Concordia's Department of Chemistry, is carrying on Curie's spirit of trail-blazing scientific inquiry, thanks to a prestigious research fellowship, created in Curie's name.
Last summer, Martn Rodrguez was one of approximately 100 scholars from across Europe to be awarded the Marie Curie Actions Research Fellowship. The award is sponsored by the European Commission, and is helping to foster her research in nanoparticles for biomedical applications.
Martn Rodrguez came to Concordia from her native Spain in October 2010 on a three-month research grant. Shortly thereafter, she received a post-doctoral fellowship from the Fundacin Alfonso Martn Escudero to continue her research at Concordia. Always one to aim high, Rodrguez then applied for a Marie Curie Actions Research Fellowship, one of the most prestigious scholarships available to emerging scientists in Europe. To her surprise and delight, she was awarded the Marie Curie in August 2011. It is worth worth more than $100,000 in salary and research funding over three years.
Thanks to the Marie Curie fellowship, the past year-and-a-half at Concordia has been especially productive for Martn Rodrguez. Along with other Concordia researchers in the Department of Chemistry, she has been working to develop nanoparticles for biomedical applications, which include more effective identification of cancer cells.
Explains Martn Rodrguez, "the idea is to develop nanoparticles capable of emitting visible light when excited with near-infrared light. That type of light is not harmful for biological specimens and can penetrate deeper in the body than light of other wavelengths. We 'decorate' these nanoparticles with either specific molecules that can
|Contact: Clea Desjardins|